E-LIB Suche - Ergebnisse für: Struemper, Herbert

1

Longitudinal efficacy and safety modeling and simulation fr..:

Collins, Jon ; van Noort, Martijn ; Rathi, Chetan...
CPT: Pharmacometrics & Systems Pharmacology. 12 (2023) 10 - p. 1411-1424 , 2023

Link: https://doi.org/10.1002/..

2

First-in-human phase I study of the OX40 agonist GSK3174998..:

Postel-Vinay, Sophie ; Lam, Vincent K ; Ros, Willeke...
Journal for ImmunoTherapy of Cancer. 11 (2023) 3 - p. e005301 , 2023

Link: https://doi.org/10.1136/..

3

P-245 Belantamab mafodotin in patients with severely impair..:

Shafi-Harji, Seema ; Nugent, Courtney ; Ferron-Brady, Geraldine...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S170-S171 , 2023

Link: https://doi.org/10.1016/..

4

Reductions in circulating B cell subsets and immunoglobulin..:

Struemper, Herbert ; Kurtinecz, Milena ; Edwards, Lisa...
Lupus Science & Medicine. 9 (2022) 1 - p. e000499 , 2022

Link: https://doi.org/10.1136/..

5

Manufacturing‐dependent change in biological activity of th..:

Steeghs, Neeltje ; Hansen, Aaron R. ; Hanna, Glenn J....
Clinical and Translational Science. 15 (2022) 11 - p. 2625-2639 , 2022

Link: https://doi.org/10.1111/..

6

Exposure–Response Analyses for Therapeutic Dose Selection o..:

Ferron‐Brady, Geraldine ; Rathi, Chetan ; Collins, Jon...
Clinical Pharmacology & Therapeutics. 110 (2021) 5 - p. 1282-1292 , 2021

Link: https://doi.org/10.1002/..

7

Population pharmacokinetics of belantamab mafodotin, a BCMA..:

Rathi, Chetan ; Collins, Jon ; Struemper, Herbert...
CPT: Pharmacometrics & Systems Pharmacology. 10 (2021) 8 - p. 851-863 , 2021

Link: https://doi.org/10.1002/..

8

P-212: DREAMM-5 platform trial: Belantamab mafodotin (belam..:

Richardson, Paul G. ; Trudel, Suzanne ; Callander, Natalie S....
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S156 , 2021

Link: https://doi.org/10.1016/..

9

Pharmacokinetics of Belimumab in Children With Systemic Lup..:

Dimelow, Richard ; Ji, Beulah ; Struemper, Herbert
Clinical Pharmacology in Drug Development. 10 (2020) 6 - p. 622-633 , 2020

Link: https://doi.org/10.1002/..

10

Safety, Pharmacokinetics, and Pharmacodynamics of the TLR4 ..:

Hug, Bruce A. ; Matheny, Christopher J. ; Burns, Olivia...
Clinical Therapeutics. 42 (2020) 8 - p. 1519-1534.e33 , 2020

Link: https://doi.org/10.1016/..

11

Safety and efficacy of intravenous belimumab in children wi..:

Brunner, Hermine I ; Abud-Mendoza, Carlos ; Viola, Diego O...
Annals of the Rheumatic Diseases. 79 (2020) 10 - p. 1340-1348 , 2020

Link: https://doi.org/10.1136/..

12

Opportunities for Quantitative Translational Modeling in On..:

Yates, James W.T. ; Byrne, Helen ; Chapman, Sonya C....
Clinical Pharmacology & Therapeutics. 108 (2020) 3 - p. 447-457 , 2020

Link: https://doi.org/10.1002/..

13

Case Examples of Using Quantitative Pharmacology in Develop..:

, In: Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune-Mediated Inflammatory Diseases,

Struemper, Herbert - p. 389-400 , 2019

Link: https://doi.org/10.1002/..

14

Population Pharmacokinetic and Pharmacodynamic Analysis of ..:

Struemper, Herbert ; Thapar, Mita ; Roth, David
Clinical Pharmacokinetics. 57 (2017) 6 - p. 717-728 , 2017

Link: https://doi.org/10.1007/..

15

Methods and strategies for assessing uncontrolled drug–drug..:

Bonate, Peter L. ; Ahamadi, Malidi ; Budha, Nageshwar...
Journal of Pharmacokinetics and Pharmacodynamics. 43 (2016) 2 - p. 123-135 , 2016

Link: https://doi.org/10.1007/..